Russia’s consumer health watchdog Rospotrebnadzor on Tuesday said Russia’s second vaccine against COVID-19 is 100 percent effective based on the results of clinical trials, the TASS news agency reported.
Russia began mass trials of EpiVacCorona, which is being developed by Siberia’s Vector Institute, in November.
Moscow has said its other approved COVID-19 vaccine, Sputnik V, is 92 percent effective at protecting people from COVID-19 according to interim results.
Coronavirus: UK hospitals use blockchain to optimize tracking of COVID-19 vaccinesTwo British hospitals are using blockchain technology to keep tabs on the storage and supply of temperature-sensitive COVID-19 vaccines, the companies ... Coronavirus
Coronavirus: India vaccine developer warns some to avoid shotIndia’s homegrown vaccine developer Bharat Biotech has warned people with weaker immunity and other medical conditions that include allergies, fever, ... Coronavirus
‘Vaccines don’t save lives, vaccinations do,’ experts warn as COVID-19 deaths riseWhile pharmaceutical companies have already managed to produce COVID-19 vaccines in record-breaking time, many people around the world remain vaccine ... Coronavirus